Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,002
Total Claims
$1.6M
Drug Cost
665
Beneficiaries
$2,362
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Opioid rate vs peers
0.1% vs 2.2% avg
+67%
Cost per patient vs peers
$2,362 vs $1,411 avg
+8%
Brand preference vs peers
11.5% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
23
Opioid Claims
$442
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,252 claims · $1.3M
Generic: 17,347 claims · $305K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 245 | $226K |
| Apixaban | 179 | $126K |
| Empagliflozin | 133 | $123K |
| Dapagliflozin Propanediol | 111 | $99K |
| Denosumab | 49 | $84K |
| Linaclotide | 101 | $70K |
| Linagliptin | 92 | $66K |
| Rivaroxaban | 77 | $57K |
| Mirabegron | 71 | $57K |
| Insulin Glargine,hum.Rec.Anlog | 85 | $44K |
| Dulaglutide | 18 | $29K |
| Fluticasone/Vilanterol | 58 | $28K |
| Insulin Aspart Prot/Insuln Asp | 11 | $21K |
| Atorvastatin Calcium | 1,524 | $20K |
| Fluticasone/Umeclidin/Vilanter | 28 | $19K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data